Abstract CT187: Overall survival (OS) by response during “induction” from the global, randomized Phase III IMvigor130 study of atezolizumab (atezo) + platinum/gemcitabine (plt/gem)... von Grande, Enrique, Bamias, Aristotelis, Galsky, Matthew D., Kikuchi, Eiji, Davis, Ian D., Arranz, José Ángel, Kalebasty, Arash Rezazadeh, Garcia del Muro, Xavier, Park, Se Hoon, De Giorgi, Ugo, Alekseev, Boris, Mencinger, Marina, Izumi, Kouji, Puente, Javier, Li, Jian-Ri, Shen, Xiaodong, Ding, Beiying, Zhu, Qian, Linsenmeier, Jeremy, De Santis, Maria

Volltext